BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. Int J Mol Sci 2017;18:E135. [PMID: 28085108 DOI: 10.3390/ijms18010135] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 D'urso G, Toscano E, Barone A, Palermo M, Dell'osso B, Di Lorenzo G, Mantovani A, Martinotti G, Fornaro M, Iasevoli F, de Bartolomeis A. Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023;121:110672. [DOI: 10.1016/j.pnpbp.2022.110672] [Reference Citation Analysis]
2 Samojedny S, Czechowska E, Pańczyszyn-trzewik P, Sowa-kućma M. Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders. IJMS 2022;23:11423. [DOI: 10.3390/ijms231911423] [Reference Citation Analysis]
3 Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Effect of quetiapine on inflammation and immunity: a systematic review. Int J Psychiatry Clin Pract 2022;:1-12. [PMID: 35913757 DOI: 10.1080/13651501.2022.2101928] [Reference Citation Analysis]
4 Falkovich R, Danielson EW, Perez de-Arce K, Wamhoff EC, Cottrell J, Sheng M, Bathe M. Perturbations of a causal synaptic molecular network in autism and schizophrenia revealed with multiplexed imaging.. [DOI: 10.1101/2022.07.11.499330] [Reference Citation Analysis]
5 de Bartolomeis A, Vellucci L, Austin MC, De Simone G, Barone A. Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics. Biomolecules 2022;12:909. [DOI: 10.3390/biom12070909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 de Bartolomeis A, Barone A, Buonaguro EF, Tomasetti C, Vellucci L, Iasevoli F. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. Neurosci Biobehav Rev 2022;136:104596. [PMID: 35248676 DOI: 10.1016/j.neubiorev.2022.104596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen X, Cui W, Liu Z, Ma W, Yang X, Tian T, Yang Y, Xie Y, Liu Y, Lin Y. Positive Neuroplastic Effect of DNA Framework Nucleic Acids on Neuropsychiatric Diseases. ACS Materials Lett . [DOI: 10.1021/acsmaterialslett.2c00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res 2022;:106078. [PMID: 35026403 DOI: 10.1016/j.phrs.2022.106078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sato S, Bunney B, Mendoza-Viveros L, Bunney W, Borrelli E, Sassone-Corsi P, Orozco-Solis R. Rapid-acting antidepressants and the circadian clock. Neuropsychopharmacology 2021. [PMID: 34837078 DOI: 10.1038/s41386-021-01241-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Fatima A, Abdullah U, Farooq M, Mang Y, Mehrjouy MM, Asif M, Ali Z, Tommerup N, Baig SM. Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families. Genes (Basel) 2021;12:1899. [PMID: 34946848 DOI: 10.3390/genes12121899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 De Berardis D, Tomasetti C, Pompili M, Serafini G, Vellante F, Fornaro M, Valchera A, Perna G, Volpe U, Martinotti G, Fraticelli S, Di Giannantonio M, Kim YK, Orsolini L. An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine. Curr Top Med Chem 2020;20:554-84. [PMID: 32003691 DOI: 10.2174/1568026620666200131100316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
12 Smith M. Neurotransmitters, neuromodulators, synapses. Mechanisms and Genetics of Neurodevelopmental Cognitive Disorders 2021. [DOI: 10.1016/b978-0-12-821913-3.00008-1] [Reference Citation Analysis]
13 Zhao X, Zhou Z. Expression and Regulation of the GABAA Receptor/STEP61 Signaling Pathway in Cerebral Cortical Neurons Treated with Emulsified Isoflurane In Vitro. ACS Chem Neurosci 2020;11:4329-35. [PMID: 33232128 DOI: 10.1021/acschemneuro.0c00586] [Reference Citation Analysis]
14 Caruso G, Grasso M, Fidilio A, Tascedda F, Drago F, Caraci F. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals (Basel) 2020;13:E457. [PMID: 33322693 DOI: 10.3390/ph13120457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
15 Coppola M, Mondola R. Opioid receptor antagonists and major depressive disorder: Current knowledge and future perspectives. Medical Hypotheses 2020;144:110215. [DOI: 10.1016/j.mehy.2020.110215] [Reference Citation Analysis]
16 Koola MM. Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond. Hum Psychopharmacol 2021;36:1-16. [PMID: 32965756 DOI: 10.1002/hup.2758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Na KS, Kim YK. Increased use of ketamine for the treatment of depression: Benefits and concerns. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110060. [PMID: 32777326 DOI: 10.1016/j.pnpbp.2020.110060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
18 Torres Jimenez N, Lines JW, Kueppers RB, Kofuji P, Wei H, Rankila A, Coyle JT, Miller RF, McLoon LK. Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis. Invest Ophthalmol Vis Sci 2020;61:16. [PMID: 32053730 DOI: 10.1167/iovs.61.2.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Baskaran R, Lai C, Li W, Tuan L, Wang C, Lee LJ, Liu C, Hwu H, Lee L. Characterization of striatal phenotypes in heterozygous Disc1 mutant mice, a model of haploinsufficiency. J Comp Neurol 2019;528:1157-72. [DOI: 10.1002/cne.24813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Yang J, Zhang L, Cao LL, Qi J, Li P, Wang XP, Sun XL. MicroRNA-99a is a Potential Target for Regulating Hypothalamic Synaptic Plasticity in the Peri/Postmenopausal Depression Model. Cells 2019;8:E1081. [PMID: 31540304 DOI: 10.3390/cells8091081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
21 Mallet N, Delgado L, Chazalon M, Miguelez C, Baufreton J. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum. Cells 2019;8:E1005. [PMID: 31470672 DOI: 10.3390/cells8091005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
22 Cromwell HC. Translating striatal activity from brain slice to whole animal neurophysiology: A guide for neuroscience research integrating diverse levels of analysis. J Neurosci Res 2019;97:1528-45. [PMID: 31257656 DOI: 10.1002/jnr.24480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Tomasetti C, Montemitro C, Fiengo AL, Santone C, Orsolini L, Valchera A, Carano A, Pompili M, Serafini G, Perna G, Vellante F, Martinotti G, Giannantonio MD, Kim Y, Nicola MD, Bellomo A, Ventriglio A, Fornaro M, Berardis DD. Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System. CPD 2019;25:381-7. [DOI: 10.2174/1381612825666190312102444] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
24 Waugh DT. Fluoride Exposure Induces Inhibition of Sodium-and Potassium-Activated Adenosine Triphosphatase (Na+, K+-ATPase) Enzyme Activity: Molecular Mechanisms and Implications for Public Health. Int J Environ Res Public Health 2019;16:E1427. [PMID: 31010095 DOI: 10.3390/ijerph16081427] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
25 Herzog DP, Wegener G, Lieb K, Müller MB, Treccani G. Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter? Int J Mol Sci 2019;20:E949. [PMID: 30813226 DOI: 10.3390/ijms20040949] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
26 Gouder L, Vitrac A, Goubran-Botros H, Danckaert A, Tinevez JY, André-Leroux G, Atanasova E, Lemière N, Biton A, Leblond CS, Poulet A, Boland A, Deleuze JF, Benchoua A, Delorme R, Bourgeron T, Cloëz-Tayarani I. Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations. Sci Rep 2019;9:94. [PMID: 30643170 DOI: 10.1038/s41598-018-36993-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
27 Kurochkina N. Multiprotein Complexes. Protein Structure and Modeling 2019. [DOI: 10.1007/978-981-13-6601-7_6] [Reference Citation Analysis]
28 Haaf M, Leicht G, Curic S, Mulert C. Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model. Curr Pharm Biotechnol 2018;19:293-307. [PMID: 29929462 DOI: 10.2174/1389201019666180620112528] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
29 De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. Int J Mol Sci 2018;19:E2888. [PMID: 30249029 DOI: 10.3390/ijms19102888] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 28.3] [Reference Citation Analysis]
30 Lichtstein D, Ilani A, Rosen H, Horesh N, Singh SV, Buzaglo N, Hodes A. Na⁺, K⁺-ATPase Signaling and Bipolar Disorder. Int J Mol Sci 2018;19:E2314. [PMID: 30087257 DOI: 10.3390/ijms19082314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
31 Kasture AS, Hummel T, Sucic S, Freissmuth M. Big Lessons from Tiny Flies: Drosophila melanogaster as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems. Int J Mol Sci 2018;19:E1788. [PMID: 29914172 DOI: 10.3390/ijms19061788] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
32 Li W, Liu J, Fan M, Li Z, Chen Y, Zhang G, Huang Z, Zhang L. Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder. Molecules 2018;23:E996. [PMID: 29695090 DOI: 10.3390/molecules23050996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Ma J, Shang S, Wang J, Zhang T, Nie F, Song X, Heping Zhao, Zhu C, Zhang R, Hao D. Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia. Psychiatry Res 2018;265:70-6. [PMID: 29684772 DOI: 10.1016/j.psychres.2018.03.080] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
34 de Bartolomeis A, Iasevoli F, Marmo F, Buonaguro EF, Avvisati L, Latte G, Tomasetti C. Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance. Eur Neuropsychopharmacol 2018;28:538-59. [PMID: 29475793 DOI: 10.1016/j.euroneuro.2018.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Manjunath GP, Ramanujam PL, Galande S. Structure function relations in PDZ-domain-containing proteins: Implications for protein networks in cellular signalling. J Biosci 2018;43:155-71. [DOI: 10.1007/s12038-017-9727-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
36 Castelli V, Brancato A, Cavallaro A, Lavanco G, Cannizzaro C. Homer2 and Alcohol: A Mutual Interaction. Front Psychiatry 2017;8:268. [PMID: 29249995 DOI: 10.3389/fpsyt.2017.00268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Uys MM, Shahid M, Harvey BH. Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective. Front Psychiatry 2017;8:144. [PMID: 28855875 DOI: 10.3389/fpsyt.2017.00144] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
38 Oda Y, Fujita Y, Oishi K, Nakata Y, Takase M, Niitsu T, Kanahara N, Shirayama Y, Hashimoto K, Iyo M. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats. Psychopharmacology 2017;234:3027-36. [DOI: 10.1007/s00213-017-4695-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]